ErbB receptors: directing key signaling networks throughout life.

@article{Holbro2004ErbBRD,
  title={ErbB receptors: directing key signaling networks throughout life.},
  author={Thomas Holbro and Nancy E Hynes},
  journal={Annual review of pharmacology and toxicology},
  year={2004},
  volume={44},
  pages={
          195-217
        }
}
  • T. HolbroN. Hynes
  • Published 16 January 2004
  • Biology
  • Annual review of pharmacology and toxicology
The epidermal growth factor (EGF)-related peptides bind the ErbB receptors, inducing the formation of different homo- and heterodimers. Receptor dimerization promotes activation of the intrinsic kinase, leading to phosphorylation of specific tyrosines located in the ErbB's cytoplasmic region. These phosphorylated residues serve as docking sites for a variety of signaling molecules whose recruitment stimulates intracellular signaling cascades, which ultimately control diverse genetic programs… 
View on PubMed
cellsignet.com
618 Citations
Highly Influential Citations
29
Background Citations
285
Methods Citations
5
Results Citations
1

Figures and Tables from this paper

618 Citations

Mechanisms of ErbB receptor negative regulation and relevance in cancer.

Targeting ERBB receptors in cancer.

  • N. Hynes
  • Biology
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2007
The ERBB family, which encompasses subgroup I of the receptor tyrosine kinase (RTK) superfamily, has four members: epidermal growth factor receptor (EGFR)/ErbB1, ErBB2, ErbB3, and ErbF4, which contain an extracellular domain that binds peptide ligands.

Transmembrane helix-helix interactions involved in ErbB receptor signaling

This review focuses on the function of the ErbB family of receptor tyrosine kinases with a special emphasis on the role of the transmembrane domain and on the mechanisms underlying regulated and deregulated signaling.

Experimental and Computational Analysis of Epidermal Growth Factor Receptor Pathway Phosphorylation Dynamics

The dynamic opposition of kinases and phosphatases within the ErbB pathway is investigated and it is shown that fast phosphorylation/dephosphorylation may provide cells with the flexibility necessary to rapidly detect and respond to changes in their extracellular environment.

G-protein-coupled receptor signaling and the EGF network in endocrine systems

Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding.

Identification of Nucleolin as New ErbB Receptors- Interacting Protein

The results demonstrate that overexpression of ErbB1 and nucleolin may lead to receptor dimerization, phosphorylation and to anchorage independent growth, leading to enhanced cell growth.

ErbB receptors and signaling pathways in cancer.

Ligand-induced ErbB receptor dimerization.

  • M. Lemmon
  • Biology, Chemistry
    Experimental cell research
  • 2009

Signaling by Non-Canonical Receptor Tyrosine Kinases ERBB3 and RYK

The work described in this dissertation attempts to understand the non-canonical signaling by ErbB3 and Ryk/Derailed using a combination of biophysical, biochemical and cell biology methods and tries to understand, for the first time, the molecular mechanism of Ryk-Wnt interaction using Drl as a model system.
...

157 References

Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency*

Alternative endocytic trafficking of ligand-ErbB complexes may tune and diversify signal transduction by EGF family ligands.

Specificity within the EGF family/ErbB receptor family signaling network

  • D. RieseD. Stern
  • Biology
    BioEssays : news and reviews in molecular, cellular and developmental biology
  • 1998
Several characteristics of hormone‐receptor interactions and receptor coupling that contribute to specificity are discussed and there are three distinct functional groups of EGF family hormones.

The ErbB signaling network: receptor heterodimerization in development and cancer

The role of ErbB receptors as normal signal transducers and their contribution to the process of malignant transformation during tumor development are concentrated on.

Ligand Discrimination in Signaling through an ErbB4 Receptor Homodimer*

The results indicate that ErbB4 activation by growth factors is not generic and suggest that individual Erb B receptors can discriminate between different EGF-like ligands within the context of a single receptor dimer.

The Catalytic Activity of the ErbB-2 Receptor Tyrosine Kinase Is Essential for Embryonic Development

It is shown that mice homozygous for the kinase-dead erbB-2 allele die at midgestation and display the same spectrum of embryonic defects seen in erb B-2 knockout mutants, suggesting that the catalytic activity of ErbB/Neu is essential for normal embryonic development.

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

The observed superior ability of ErbB-2 to form heterodimers, in conjunction with its uniquely high basal tyrosine kinase activity, may explain why Erb B-2 overexpression is associated with poor prognosis.

ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner

Differential receptor phosphorylation may be the basis for the differences in the signaling properties observed, and tryptic phosphopeptide mapping of both ErbB-1 and ErBB-2 revealed that receptorosphorylation is dependent on the dimerization partner.

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.

The ErbB receptors and their role in cancer progression.

All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*)

Results show that the ligand-dependent down-regulation mechanism of the EGF receptor, surprisingly, is not a property of any other known ErbB receptor family member, and imply that substantial differences in attenuation mechanisms exist within one family of structurally related receptors.
...